Biogen plans hefty bond offering following fixed income investor calls on Friday

By Cristal Cody

Tupelo, Miss., April 24 – Biogen Inc. (Baa1/A-) plans to price a major offering of senior notes in the immediate future following fixed income investor calls held Friday, according to a market source.

BofA Securities, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC are the arrangers.

Biogen was last in the high-grade primary market on Sept. 10, 2015 when it sold $6 billion of senior notes in four tranches.

The biotechnology company is based in Cambridge, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.